Lisata Therapeutics Inc. (LSTA) stock news · rev $170.0K
Lisata Therapeutics Inc. (LSTA) is a biotechnology company listed on US.
This LSTA news page leads with what Lisata Therapeutics Inc. filed — not a scraped headline mill.
No cached 8-K sentence for LSTA yet. We will not pad this page with generic market recap.
Latest reported LSTA revenue for 2025-12-31 was $170.0K. Net income was -$16.6M. Revenue was down 83.0% from 2024-12-31 to 2025-12-31. LSTA currently screens at market cap $31.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the LSTA stock page; for the tape open the quote page.
LSTA stock news FAQ
What are LSTA's latest revenue and net income?
Latest cached Lisata Therapeutics Inc. (LSTA) revenue for Dec 31, 2025 was $170.0K. Net income was -$16.6M. Statements: https://lician.com/financials/lsta
How did LSTA revenue change from the prior cached period?
Cached Lisata Therapeutics Inc. (LSTA) revenue was down 83.0% from $1.0M (Dec 31, 2024) to $170.0K (Dec 31, 2025). Statements: https://lician.com/financials/lsta
What is LSTA's market cap?
Lisata Therapeutics Inc. (LSTA) market cap is $31.7M on the latest cached fundamentals snapshot.
What kind of company is LSTA?
Lisata Therapeutics Inc. (LSTA) is a biotechnology company listed on US.
Where is LSTA stock news listed?
Cached stock news for Lisata Therapeutics Inc. (LSTA) is listed at https://lician.com/news/lsta. Filings: https://lician.com/sec/lsta
Not investment advice.